US20080260810A1 - Hemostat - Google Patents

Hemostat Download PDF

Info

Publication number
US20080260810A1
US20080260810A1 US11/577,207 US57720705A US2008260810A1 US 20080260810 A1 US20080260810 A1 US 20080260810A1 US 57720705 A US57720705 A US 57720705A US 2008260810 A1 US2008260810 A1 US 2008260810A1
Authority
US
United States
Prior art keywords
hemostat
cellulose
foam
knitted fabric
thrombin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/577,207
Other languages
English (en)
Inventor
Guanghui Zhang
Sonia Martins
Robin Barone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Omrix Biopharmaceuticals SA
Ethicon Inc
Original Assignee
Omrix Biopharmaceuticals SA
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omrix Biopharmaceuticals SA, Ethicon Inc filed Critical Omrix Biopharmaceuticals SA
Priority to US11/577,207 priority Critical patent/US20080260810A1/en
Assigned to ETHICON, INC., OMRIX BIOPHARMACEUTICALS, INC. reassignment ETHICON, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BARONE, ROBIN, MARTINS, SONIA, ZHANG, GUANGHUI
Publication of US20080260810A1 publication Critical patent/US20080260810A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/01—Non-adhesive bandages or dressings
    • A61F13/01021—Non-adhesive bandages or dressings characterised by the structure of the dressing
    • A61F13/01029—Non-adhesive bandages or dressings characterised by the structure of the dressing made of multiple layers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/64—Use of materials characterised by their function or physical properties specially adapted to be resorbable inside the body
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B23/00—Layered products comprising a layer of cellulosic plastic substances, i.e. substances obtained by chemical modification of cellulose, e.g. cellulose ethers, cellulose esters, viscose
    • B32B23/02—Layered products comprising a layer of cellulosic plastic substances, i.e. substances obtained by chemical modification of cellulose, e.g. cellulose ethers, cellulose esters, viscose in the form of fibres or filaments
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B23/00—Layered products comprising a layer of cellulosic plastic substances, i.e. substances obtained by chemical modification of cellulose, e.g. cellulose ethers, cellulose esters, viscose
    • B32B23/10—Layered products comprising a layer of cellulosic plastic substances, i.e. substances obtained by chemical modification of cellulose, e.g. cellulose ethers, cellulose esters, viscose next to a fibrous or filamentary layer
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B27/00—Layered products comprising a layer of synthetic resin
    • B32B27/36—Layered products comprising a layer of synthetic resin comprising polyesters
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B5/00—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts
    • B32B5/02—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by structural features of a fibrous or filamentary layer
    • B32B5/022—Non-woven fabric
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B5/00—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts
    • B32B5/02—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by structural features of a fibrous or filamentary layer
    • B32B5/024—Woven fabric
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B5/00—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts
    • B32B5/02—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by structural features of a fibrous or filamentary layer
    • B32B5/026—Knitted fabric
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B5/00—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts
    • B32B5/22—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by the presence of two or more layers which are next to each other and are fibrous, filamentary, formed of particles or foamed
    • B32B5/24—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by the presence of two or more layers which are next to each other and are fibrous, filamentary, formed of particles or foamed one layer being a fibrous or filamentary layer
    • B32B5/26—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by the presence of two or more layers which are next to each other and are fibrous, filamentary, formed of particles or foamed one layer being a fibrous or filamentary layer another layer next to it also being fibrous or filamentary
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • A61L2300/608—Coatings having two or more layers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2250/00—Layers arrangement
    • B32B2250/20—All layers being fibrous or filamentary
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2262/00—Composition or structural features of fibres which form a fibrous or filamentary layer or are present as additives
    • B32B2262/02—Synthetic macromolecular fibres
    • B32B2262/0276—Polyester fibres
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2262/00—Composition or structural features of fibres which form a fibrous or filamentary layer or are present as additives
    • B32B2262/04—Cellulosic plastic fibres, e.g. rayon
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2262/00—Composition or structural features of fibres which form a fibrous or filamentary layer or are present as additives
    • B32B2262/06—Vegetal fibres
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2262/00—Composition or structural features of fibres which form a fibrous or filamentary layer or are present as additives
    • B32B2262/06—Vegetal fibres
    • B32B2262/062—Cellulose fibres, e.g. cotton
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2307/00—Properties of the layers or laminate
    • B32B2307/70—Other properties
    • B32B2307/726—Permeability to liquids, absorption
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2556/00—Patches, e.g. medical patches, repair patches
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
    • Y10T442/20—Coated or impregnated woven, knit, or nonwoven fabric which is not [a] associated with another preformed layer or fiber layer or, [b] with respect to woven and knit, characterized, respectively, by a particular or differential weave or knit, wherein the coating or impregnation is neither a foamed material nor a free metal or alloy layer
    • Y10T442/2525—Coating or impregnation functions biologically [e.g., insect repellent, antiseptic, insecticide, bactericide, etc.]

Definitions

  • the present invention relates to a hemostat.
  • the control of bleeding, as well as sealing of air and various bodily fluids is essential and critical in surgical procedures to minimize blood loss, to seal tissue and organ structures, to reduce post-surgical complications, and to shorten the duration of the surgery in the operating room.
  • therapeutic agents including, but not limited to, thrombin, fibrin and fibrinogen have been combined with dressing carriers or substrates, including gelatin-based carriers, polysaccharide-based carriers, glycolic acid or lactic acid-based carriers and a collagen matrix.
  • dressing carriers or substrates including gelatin-based carriers, polysaccharide-based carriers, glycolic acid or lactic acid-based carriers and a collagen matrix. Examples of such dressings are disclosed in U.S. Pat. No. 6,762,336, U.S. Pat. No. 6,733,774 and PCT publication WO 2004/064878 A1.
  • carboxylic-oxidized cellulose Due to its biodegradability and its bactericidal, tissue sealing, tissue repairing, drug delivering and hemostatic properties, it is desirable to utilize cellulose that has been oxidized to contain carboxylic acid moieties, hereinafter referred to as carboxylic-oxidized cellulose, as a topical dressing in a variety of surgical procedures, including neurosurgery, abdominal surgery, cardiovascular surgery, thoracic surgery, head and neck surgery, pelvic surgery and skin and subcutaneous tissue procedures.
  • the present invention is directed towards a hemostat comprising an absorbable foam, an absorbable woven or knitted fabric, thrombin and fibrinogen.
  • the hemostat described herein provides and maintains effective hemostasis when applied to a wound requiring hemostasis.
  • Effective hemostasis is the ability to control and/or abate capillary, venous, or arteriole bleeding within an effective time, as recognized by those skilled in the art of hemostasis. Further indications of effective hemostasis may be provided by governmental regulatory standards and the like.
  • hemostats of the present invention are effective in providing and maintaining hemostasis in cases of severe or brisk bleeding.
  • severe bleeding is meant to include those cases of bleeding where a relatively high volume of blood is lost at a relatively high rate.
  • severe bleeding include, without limitation, bleeding due to arterial puncture, liver resection, blunt liver trauma, blunt spleen trauma, aortic aneurysm, bleeding from patients with over-anticoagulation, or bleeding from patients with coagulopathies, such as hemophilia.
  • the hemostat generally comprises an absorbable foam and a reinforcement fabric.
  • the reinforcement fabric provides a backing to which the foam may be attached, either directly or indirectly, wherein thrombin and fibrinogen are substantially homogeneously dispersed throughout the foam and/or are disposed on the surface of the foam.
  • the reinforcement fabric provides strength to the hemostat sufficient to permit the user to place and manipulate the hemostat on or within a wound or directly onto tissue of a patient requiring hemostasis, or tissue sealing and adhering.
  • the foam In addition to serving as a carrier for the thrombin and fibrinogen, the foam also serves to shield the thrombin and fibrinogen from acidic moieties that may be present in the reinforcement fabric, such as is the case where carboxylic-oxidized cellulose is used as the reinforcement fabric.
  • the foam may be a biocompatible, water-soluble, or water-swellable polymer and a foaming agent/surfactant.
  • Preferred biocompatible, water-soluble, or water-swellable polymers used to fabricate the foam include polysaccharides.
  • Such polysaccharides include, without limitation, cellulose, alkyl cellulose, e.g. methylcellulose, alkylhydroxyalkyl cellulose, hydroxyalkyl cellulose, cellulose sulfate, salts of carboxymethyl cellulose, carboxymethyl cellulose, and carboxyethyl cellulose.
  • albumin chitin, carboxymethyl chitin, hyaluronic acid, salts of hyaluronic acid, alginate, alginic acid, propylene glycol alginate, glycogen, dextran, dextran sulfate, curdlan, pectin, pullulan, xanthan, chondroitin, chondroitin sulfates, carboxymethyl dextran, carboxymethyl chitosan, chitosan, heparin, heparin sulfate, heparan, heparan sulfate, dermatan sulfate, keratan sulfate, carrageenans, chitosan, starch, amylose, amylopectin, poly-N-glucosamine, polymannuronic acid, polyglucuronic acid polyguluronic acid, and derivatives of any of the above, may be utilized. Even more preferably, biocompatible, water-soluble, or water-
  • the foaming agent/surfactant may be a cationic, anionic, amphoteric, zwitterionic or nonionic surfactant, or natural or modified proteins, including but without limitation, albumin, sodium lauryl sulfate, sodium laureth sulfate, or ammonia lauryl sulfate.
  • a preferred foaming agent/surfactant is albumin, and more preferably, human serum albumin (HSA).
  • the reinforcement fabric is an absorbable woven or knitted fabric and comprises oxidized polysaccharides, in particular oxidized cellulose and the neutralized derivatives thereof.
  • the cellulose may be carboxylic-oxidized or aldehyde-oxidized cellulose. More preferably, oxidized regenerated polysaccharides, including but without limitation oxidized regenerated cellulose, may be used to prepare the second absorbable woven or knitted fabric.
  • Regenerated cellulose is preferred due to its higher degree of uniformity versus cellulose that has not been regenerated.
  • Regenerated cellulose and a detailed description of how to make oxidized regenerated cellulose are set forth in U.S. Pat. No. 3,364,200, U.S. Pat. No. 5,180,398 and U.S. Pat. No. 4,626,253, the contents each of which is hereby incorporated by reference as if set forth in its entirety.
  • fabrics that may be utilized as the reinforcement fabric include, but are not limited to, Interceed® absorbable adhesion barrier, Surgicel® absorbable hemostat, Surgicel Nu-Knit® absorbable hemostat and Surgicel® Fibrillar absorbable hemostat (each available from Johnson & Johnson Wound Management Worldwide or Gynecare Worldwide, each a division of Ethicon, Inc., Somerville, N.J.).
  • the reinforcement fabric utilized in the present invention may be woven or knitted, provided that the fabric possesses the physical properties necessary for use in contemplated applications. Such fabrics, for example, are described in U.S. Pat. No. 4,626,253, U.S. Pat. No. 5,002,551 and U.S. Pat. No. 5,007,916, the contents of which are hereby incorporated by reference herein as if set forth in its entirety.
  • the reinforcement fabric is a warp knitted tricot fabric constructed of bright rayon yarn that is subsequently oxidized to include carboxyl or aldehyde moieties in amounts effective to provide the fabrics with biodegradability.
  • the reinforcement fabric comprises oxidized polysaccharide fibers in combination with fibers comprised of aliphatic polyester polymers, copolymers, or blends thereof.
  • the reinforcement fabric preferably comprises oxidized regenerated cellulose and may have a basis weight ranging from about 0.001 to 0.2 g/in 2 , preferably in the range of about 0.01 to 0.1 g/in 2 , and most preferably in the range of about 0.04 to 0.07 g/in 2 .
  • a foam slurry may be prepared from, for example, CMC-Na and HSA, and then spread on the surface of, for example, an oxidized regenerated cellulose fabric.
  • the ratio of the water-soluble or water-swellable polymer to the foaming agent may range from about 1:8 to 8:1 by weight, and preferably from about 2:1 to 1:2 by weight.
  • the foam slurry is then dried either by lyophilization or in an oven at elevated temperature to form a solid foam substrate.
  • the foam substrate may be treated with a chemical cross-linking agent such as glutaraldehyde for increased strength or may be partly cross-linked by heating.
  • the density of the hemostat may be from about 5 to 20 mg/cm 3 .
  • the thrombin and fibrinogen may be animal derived, preferably human, or may be recombinant.
  • the thrombin activity on the hemostat may be in the range of about 20 to 500 IU/cm 2 , preferably about 20 to 200 IU/cm 2 , and most preferably about 50 to 200 IU/cm 2 .
  • the fibrinogen activity on the hemostat may be in the range of about 2 to 15 mg/cm 2 , preferably about 3 to 10 mg/cm 2 , and most preferably about 4 to 7 mg/cm 2 .
  • Thrombin powders may be prepared by lyophilization of thrombin solutions.
  • Fibrinogen may be prepared by lyophilizaton of solutions containing fibrinogen, such as those described in U.S. Pat. No. 6,121,232 and PCT Application Publication No. WO 02/095019. Dry powders of fibrinogen and thrombin suspended in an organic solvent such as PF5060 or HFE 7000-7300 series are then sprayed onto the surface of the foam. Alternatively, the thrombin and fibrinogen may be incorporated into the foam during the foam production.
  • the hemostat may comprise a first foam having incorporated thereon or therein a first therapeutic agent, e.g., fibrinogen, and a second foam separate (unattached) from the first foam that may have upon or incorporated therein powders of a second therapeutic agent, e.g. thrombin.
  • a hemostat may comprise a reinforcement fabric having a first foam adjacent thereto and second foam on the other side of the first foam. While either thrombin or fibrinogen may be incorporated into first foam, fibrinogen is preferred. While either thrombin or fibrinogen may be incorporated with the second foam, thrombin is preferred.
  • the foam slurries used to prepare the first and second foams are selected such that the second foam is less dense than the first foam so that it liquefies or melts quickly after coming into contact with blood at the wound site to start the clotting process.
  • the second foam contacts the bleeding site first, then the combined reinforcing layer and first foam keeps the clot from being washed away by the blood flow.
  • the hemostat may optionally include without limitation, procoagulant enzymes, proteins and peptides, may be naturally occurring, recombinant, or synthetic, and may be selected from the group consisting of prothrombin, fibrin, fibronectin, heparinase, Factor X/Xa, Factor VII/VIIa, Factor IX/IXa, Factor XI/XIa, Factor XII/XIIa, tissue factor, batroxobin, ancrod, ecarin, von Willebrand Factor, collagen, elastin, albumin, gelatin, platelet surface glycoproteins, vasopressin and vasopressin analogs, epinephrine, selectin, procoagulant venom, plasminogen activator inhibitor, platelet activating agents, synthetic peptides having hemostatic activity, derivatives of the above and any combination thereof.
  • prothrombin fibrin, fibronectin, heparinase
  • the hemostat described herein may also be used as an adjunct to primary wound closure devices, such as arterial closure devices, staples, and sutures, to seal potential leaks of gasses, liquids, or solids as well as to provide hemostasis.
  • primary wound closure devices such as arterial closure devices, staples, and sutures
  • the hemostat may be utilized to seal air from tissue or fluids from organs and tissues, including but not limited to, bile, lymph, cerebrospinal fluids, gastrointestinal fluids, interstitial fluids and urine.
  • the hemostat described herein has additional medical applications and may be used for a variety of clinical functions, including but not limited to tissue reinforcement and buttressing, i.e., for gastrointestinal or vascular anastomoses, approximation, i.e., to connect anastomoses that are difficult to perform (i.e. under tension), and tension releasing.
  • the hemostat may additionally promote and possibly enhance the natural tissue healing process in all the above events.
  • This hemostat can be used internally in many types of surgery, including, but not limited to, cardiovascular, peripheral-vascular, cardio-thoracic, gynecological, neuro- and general surgery.
  • the hemostat may also be used to attach medical devices (e.g. meshes, clips and films) to tissues, tissue to tissue, or medical device to medical device.
  • CMC-Na sodium carboxy methylcellulose
  • HSA human serum albumin
  • CMC-Na sodium carboxy methylcellulose
  • HSA human serum albumin
  • Hemostatic agents were applied to the constructs prepared in Examples 1 and 2 as below.
  • the constructs were cut into 3′′ ⁇ 4′′ pieces.
  • Lyophilized thrombin and Biological Active Components 2 (BAC-2) containing fibrinogen were ground to powder separately.
  • the thrombin powder and the BAC-2 powder were passed through a 45-micrometer sieve.
  • the two powders were weighed to provide a final fibrinogen concentration of 6 mg/cm 2 , 7 mg/cm 2 or 8 mg/cm 2 , and a thrombin activity of 50 IU/cm 2 .
  • the powders were then mixed and suspended in a per-fluorinated solvent HFE 7000 in a flask. The suspension then was sprayed onto the various constructs and then dried under nitrogen at room temperature for 1 hour.
  • CMC-Na sodium carboxy methylcellulose
  • HSA human serum albumin
  • CMC-Na sodium carboxy methylcellulose
  • HSA human serum albumin
  • a severe bleeding wound was made on a swine liver.
  • the defect was created by making a triangular cut with a surgical scalpel. Each side measured about 1 inch and the depth measured 5 mm.
  • CMC-Na/HSA/Thrombin foam (1′′ ⁇ 1′′) was quickly applied to the wound.
  • a piece of CMC-Na/HSA/Fibrinogen foam was then applied on top of the thrombin foam followed by manual compression. Hemostasis was achieved in 2 minutes.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Textile Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Laminated Bodies (AREA)
US11/577,207 2004-10-20 2005-10-17 Hemostat Abandoned US20080260810A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/577,207 US20080260810A1 (en) 2004-10-20 2005-10-17 Hemostat

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US62053904P 2004-10-20 2004-10-20
US69625805P 2005-07-01 2005-07-01
PCT/US2005/037403 WO2006044879A2 (fr) 2004-10-20 2005-10-17 Hemostatique
US11/577,207 US20080260810A1 (en) 2004-10-20 2005-10-17 Hemostat

Publications (1)

Publication Number Publication Date
US20080260810A1 true US20080260810A1 (en) 2008-10-23

Family

ID=36120942

Family Applications (4)

Application Number Title Priority Date Filing Date
US11/252,121 Abandoned US20060093655A1 (en) 2004-10-20 2005-10-17 Method for making a reinforced absorbable multilayered hemostatic wound dressing
US11/577,207 Abandoned US20080260810A1 (en) 2004-10-20 2005-10-17 Hemostat
US11/252,175 Abandoned US20060088589A1 (en) 2004-10-20 2005-10-17 Reinforced absorbable multilayered hemostatic wound dressing
US11/400,849 Active 2030-04-08 US9439997B2 (en) 2004-10-20 2006-04-10 Reinforced absorbable multilayered hemostatis wound dressing

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US11/252,121 Abandoned US20060093655A1 (en) 2004-10-20 2005-10-17 Method for making a reinforced absorbable multilayered hemostatic wound dressing

Family Applications After (2)

Application Number Title Priority Date Filing Date
US11/252,175 Abandoned US20060088589A1 (en) 2004-10-20 2005-10-17 Reinforced absorbable multilayered hemostatic wound dressing
US11/400,849 Active 2030-04-08 US9439997B2 (en) 2004-10-20 2006-04-10 Reinforced absorbable multilayered hemostatis wound dressing

Country Status (16)

Country Link
US (4) US20060093655A1 (fr)
EP (4) EP1809343B1 (fr)
JP (2) JP5191736B2 (fr)
KR (2) KR20070095870A (fr)
CN (1) CN102091347A (fr)
AU (2) AU2005295365B2 (fr)
BR (2) BRPI0516764B8 (fr)
CA (2) CA2584698C (fr)
DK (3) DK1809342T3 (fr)
ES (3) ES2391641T3 (fr)
FR (1) FR14C0026I1 (fr)
HK (2) HK1130704A1 (fr)
IL (2) IL182565A (fr)
PL (1) PL1809342T3 (fr)
TW (2) TWI401097B (fr)
WO (2) WO2006044879A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110237994A1 (en) * 2010-03-25 2011-09-29 Combat Medical Systems, Llc Void-filling wound dressing
WO2015079433A1 (fr) 2013-11-26 2015-06-04 Omrix Biopharmaceuticals Ltd. Tampon sec comprenant de la thrombine et de la pectine

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9358318B2 (en) 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
KR20130060276A (ko) 2004-10-20 2013-06-07 에디컨인코포레이티드 의료 장치에 사용하기 위한 강화 흡수성 다층 직물 및 이의 제조방법
DK1809342T3 (en) * 2004-10-20 2015-08-17 Ethicon Inc absorbable hemostat
CA2649081A1 (fr) * 2006-04-10 2007-10-18 Ethicon, Inc. Pansement hemostatique multicouche absorbable, renforce et procede de production
AU2006341589A1 (en) * 2006-04-10 2007-10-18 Ethicon, Inc. A reinforced absorbable multilayered fabric for use in medical devices and method of manufacture
NZ574653A (en) * 2006-08-04 2012-11-30 Stb Lifesaving Technologies Inc Solid dressing for treating wounded tissue
GB0623607D0 (en) 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
US20090004253A1 (en) * 2007-06-29 2009-01-01 Brown Laura J Composite device for the repair or regeneration of tissue
US20090036907A1 (en) * 2007-07-30 2009-02-05 Yves Bayon Bioresorbable knit
GB2461019B (en) * 2008-04-25 2013-06-05 Medtrade Products Ltd Haemostatic material
WO2010002435A2 (fr) * 2008-07-03 2010-01-07 Kulinets Irina B Poche hémostatique et procédé pour stabiliser des composants hémostatiques
EP2477617B1 (fr) 2009-09-18 2018-01-31 Bioinspire Technologies Inc. Timbre biodégradable autonome
US8349354B2 (en) * 2009-09-22 2013-01-08 Ethicon, Inc. Composite layered hemostasis device
WO2011127591A1 (fr) * 2010-04-15 2011-10-20 Covalon Technologies Inc. Protections tissulaires renforcées
US8273369B2 (en) * 2010-05-17 2012-09-25 Ethicon, Inc. Reinforced absorbable synthetic matrix for hemostatic applications
CN101890181B (zh) * 2010-06-12 2014-04-30 广州倍绣生物技术有限公司 一种猪源纤维蛋白胶粉雾剂及其制备方法和应用
KR101833035B1 (ko) 2011-05-24 2018-02-27 다케다 에이에스 롤형 콜라겐 담체
US8998059B2 (en) 2011-08-01 2015-04-07 Ethicon Endo-Surgery, Inc. Adjunct therapy device having driver with cavity for hemostatic agent
US9492170B2 (en) 2011-08-10 2016-11-15 Ethicon Endo-Surgery, Inc. Device for applying adjunct in endoscopic procedure
CN103797182B (zh) * 2011-09-12 2016-05-04 郡是株式会社 亲水化纤维素纤维的制造方法
US9101359B2 (en) 2011-09-13 2015-08-11 Ethicon Endo-Surgery, Inc. Surgical staple cartridge with self-dispensing staple buttress
US8998060B2 (en) 2011-09-13 2015-04-07 Ethicon Endo-Surgery, Inc. Resistive heated surgical staple cartridge with phase change sealant
US9999408B2 (en) 2011-09-14 2018-06-19 Ethicon Endo-Surgery, Inc. Surgical instrument with fluid fillable buttress
US9125649B2 (en) 2011-09-15 2015-09-08 Ethicon Endo-Surgery, Inc. Surgical instrument with filled staple
US9254180B2 (en) 2011-09-15 2016-02-09 Ethicon Endo-Surgery, Inc. Surgical instrument with staple reinforcement clip
US8814025B2 (en) 2011-09-15 2014-08-26 Ethicon Endo-Surgery, Inc. Fibrin pad matrix with suspended heat activated beads of adhesive
US9393018B2 (en) 2011-09-22 2016-07-19 Ethicon Endo-Surgery, Inc. Surgical staple assembly with hemostatic feature
US9198644B2 (en) 2011-09-22 2015-12-01 Ethicon Endo-Surgery, Inc. Anvil cartridge for surgical fastening device
US8985429B2 (en) 2011-09-23 2015-03-24 Ethicon Endo-Surgery, Inc. Surgical stapling device with adjunct material application feature
US20130084324A1 (en) * 2011-09-30 2013-04-04 Michel Gensini Adhesion prevention fabric
US8899464B2 (en) 2011-10-03 2014-12-02 Ethicon Endo-Surgery, Inc. Attachment of surgical staple buttress to cartridge
US9089326B2 (en) 2011-10-07 2015-07-28 Ethicon Endo-Surgery, Inc. Dual staple cartridge for surgical stapler
US8900822B2 (en) 2011-11-21 2014-12-02 Ethicon, Inc. Fibrinogen assay
US9056092B2 (en) * 2011-12-02 2015-06-16 Ethicon, Inc. Hemostatic bioabsorbable device with polyethylene glycol binder
MY173719A (en) 2012-05-14 2020-02-18 Teijin Pharma Ltd Formed sheet product and hemostatic material
IN2014DN09624A (fr) * 2012-05-14 2015-07-31 Teijin Ltd
US10485715B2 (en) 2012-05-24 2019-11-26 Takeda As Packaging for form-stable coiled collagen carrier
RU2670746C9 (ru) 2012-05-24 2018-12-20 Такеда Ас Способ и аппарат для получения свернутого коллагенового носителя
US11071805B2 (en) 2013-04-22 2021-07-27 Sealantium Medical Ltd. Fibrinogen-based tissue adhesive patches
US10765774B2 (en) * 2013-07-09 2020-09-08 Ethicon, Inc. Hemostatic pad assembly kit and method
CN103446619B (zh) * 2013-08-19 2015-08-19 青岛中腾生物技术有限公司 新型可吸收止血材料
US10456129B2 (en) 2013-11-08 2019-10-29 Ethicon Llc Positively charged implantable materials and method of forming the same
US9936950B2 (en) 2013-11-08 2018-04-10 Ethicon Llc Hybrid adjunct materials for use in surgical stapling
US9700311B2 (en) 2013-11-08 2017-07-11 Ethicon Llc Tissue ingrowth materials and method of using the same
JP5988406B2 (ja) * 2014-04-30 2016-09-07 マルホ株式会社 起泡性組成物
US9801630B2 (en) 2014-06-10 2017-10-31 Ethicon Llc Methods and devices for reinforcing a staple line
US9848871B2 (en) 2014-06-10 2017-12-26 Ethicon Llc Woven and fibrous materials for reinforcing a staple line
US9913646B2 (en) 2014-06-10 2018-03-13 Ethicon Llc Devices for sealing staples in tissue
US10206686B2 (en) 2014-06-10 2019-02-19 Ethicon Llc Bronchus sealants and methods of sealing bronchial tubes
US10172611B2 (en) 2014-06-10 2019-01-08 Ethicon Llc Adjunct materials and methods of using same in surgical methods for tissue sealing
US20150351753A1 (en) 2014-06-10 2015-12-10 Ethicon Endo-Surgery, Inc. Methods and Devices for Reinforcing a Staple Line
US9826965B2 (en) 2014-06-10 2017-11-28 Ethicon Llc Devices for sealing a body lumen
KR101878774B1 (ko) * 2015-04-15 2018-07-17 주식회사 삼양바이오팜 다기능성 지혈제 및 그 제조 방법
FR3035666B1 (fr) 2015-04-30 2018-03-02 Mdb Texinov Structure textile tricote a zones differenciees
WO2016178829A1 (fr) * 2015-05-06 2016-11-10 Gyrus Acmi, Inc. (D.B.A. Olympus Surgical Technologies America) Formulation d'éponge à carboxyméthylchitosane
MA42610A (fr) 2015-08-14 2018-06-20 Ethicon Inc Procédé de traitement de maladie à l'aide de composé dépendant glycolytique
KR102576293B1 (ko) 2015-11-06 2023-09-08 에디컨인코포레이티드 압밀된 지혈 셀룰로오스 집합체
US11413335B2 (en) 2018-02-13 2022-08-16 Guangzhou Bioseal Biotech Co. Ltd Hemostatic compositions and methods of making thereof
CN107754005B (zh) * 2016-08-15 2021-06-15 广州倍绣生物技术有限公司 止血组合物及其制造方法
IL247786B (en) 2016-09-12 2019-08-29 Plotkin Alexander Covers the wound with a hemostatic action and method and creates it
US10245817B2 (en) 2016-09-16 2019-04-02 Ethicon, Inc. Method of laminating absorbable semi-crystalline polymeric films
US11254061B2 (en) 2017-01-06 2022-02-22 Ethicon, Inc. Scaffolds for implanting absorbable hemostats in field conditions
IL256405A (en) 2017-12-19 2018-01-31 Omrix Biopharmaceuticals Ltd Wound bandage and method for its production
US20210162095A1 (en) * 2018-02-15 2021-06-03 Biom'up France SAS Multi-dimensional hemostatic product and method for producing the same
USD885574S1 (en) 2018-02-21 2020-05-26 Ethicon Llc Knitted tissue scaffold
CN112040884A (zh) 2018-02-21 2020-12-04 爱惜康有限责任公司 针织组织支架
US20190254668A1 (en) 2018-02-21 2019-08-22 Ethicon Llc Knitted tissue scaffolds
KR20210018788A (ko) 2018-03-22 2021-02-18 씨랜티움 메디컬 리미티드 지혈 조직 실런트 패치의 접착력 평가 방법
US11885735B2 (en) 2019-09-13 2024-01-30 Ethicon, Inc. Ex vivo and in vivo systems for evaluating hemostatic patches, sealants, adhesives on solid organs
JP7397646B2 (ja) * 2019-12-12 2023-12-13 グンゼ株式会社 自動縫合器用縫合補強材
US11826028B2 (en) * 2020-06-10 2023-11-28 Ethicon, Inc. Two component sealing systems including synthetic matrices and biosynthetic adhesives for sealing resected surfaces of organs to control bleeding, fluid leaks and air leaks
US11678883B2 (en) 2020-11-25 2023-06-20 Cilag Gmbh International Compressible knitted adjuncts with varying interconnections
US11707279B2 (en) 2020-11-25 2023-07-25 Cilag Gmbh International Compressible knitted adjuncts with finished edges
US11446027B2 (en) 2020-11-25 2022-09-20 Cilag Gmbh International Compressible knitted adjuncts with surface features
US11690617B2 (en) 2020-11-25 2023-07-04 Cilag Gmbh International Compressible knitted adjuncts with finished edges
US11648007B2 (en) 2020-11-25 2023-05-16 Cilag Gmbh International Compressible knitted adjuncts with varying fiber features

Citations (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2517772A (en) * 1945-05-11 1950-08-08 Parke Davis & Co Neutralized oxidized cellulose products
US2772999A (en) * 1952-06-06 1956-12-04 Johnson & Johnson Hemostatic surgical compositions and dressings
US2773000A (en) * 1952-06-06 1956-12-04 Johnson & Johnson Hemostatic surgical dressings
US2914444A (en) * 1950-12-12 1959-11-24 David F Smith Cellulosic hemostatic composition
US3113568A (en) * 1961-12-26 1963-12-10 Eric K Erskine Styptic bandage
US3122479A (en) * 1957-11-14 1964-02-25 David F Smith Hemostatic surgical dressings
US3328529A (en) * 1964-08-31 1967-06-27 Heath Co Phase shifting circuit for fm stereo receiver
US3364200A (en) * 1960-03-28 1968-01-16 Johnson & Johnson Oxidized cellulose product and method for preparing the same
US3868955A (en) * 1973-10-05 1975-03-04 Personal Products Co Aldehyde polysaccharide dressings
US3875937A (en) * 1963-10-31 1975-04-08 American Cyanamid Co Surgical dressings of absorbable polymers
US4176664A (en) * 1978-03-13 1979-12-04 Stanley Kalish Impregnated bandage
US4265233A (en) * 1978-04-12 1981-05-05 Unitika Ltd. Material for wound healing
US4289824A (en) * 1977-04-22 1981-09-15 Avtex Fibers Inc. High fluid-holding alloy rayon fiber mass
US4334530A (en) * 1980-09-12 1982-06-15 Hassell Donald S Indicia-bearing adhesive bandages
US4347841A (en) * 1981-03-11 1982-09-07 Human Oltoanyagtermelo Es Kutato Intezet Biological wound covering and method for producing same
US4366169A (en) * 1979-06-25 1982-12-28 Sun Tech, Inc. Use of perfluorocarbons as wound treatment
US4407787A (en) * 1980-10-03 1983-10-04 Dr. Ruhland Nachf. Gmbh Collagenous dressing
US4427650A (en) * 1981-06-25 1984-01-24 Serapharm Michael Stroetmann Enriched plasma derivative for advancement of wound closure and healing
US4427651A (en) * 1981-06-25 1984-01-24 Serapharm Michael Stroetmann Enriched plasma derivative for enhancement of wound closure and coverage
US4442655A (en) * 1981-06-25 1984-04-17 Serapharm Michael Stroetmann Fibrinogen-containing dry preparation, manufacture and use thereof
US4453939A (en) * 1981-02-16 1984-06-12 Hormon-Chemie Munchen Gmbh Composition for sealing and healing wounds
US4543410A (en) * 1982-06-21 1985-09-24 Morca, Inc. Absorbent cellulosic base structures
US4600574A (en) * 1984-03-21 1986-07-15 Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte Method of producing a tissue adhesive
US4616644A (en) * 1985-06-14 1986-10-14 Johnson & Johnson Products, Inc. Hemostatic adhesive bandage
US4655211A (en) * 1984-08-09 1987-04-07 Unitika Ltd. Hemostatic agent
US4704113A (en) * 1983-05-03 1987-11-03 The Kendall Company Dressing
US4752466A (en) * 1987-08-31 1988-06-21 Johnson & Johnson Products, Inc. Thrombin aerosol
US4769028A (en) * 1983-04-27 1988-09-06 Lohmann Gmbh & Co. Kg Pharmaceutical product, in medical bandage form
US4840626A (en) * 1986-09-29 1989-06-20 Johnson & Johnson Patient Care, Inc. Heparin-containing adhesion prevention barrier and process
US4858604A (en) * 1981-12-09 1989-08-22 Nippon Zoki Pharmaceutical Co., Ltd. Adhesive bandage
US4902281A (en) * 1988-08-16 1990-02-20 Corus Medical Corporation Fibrinogen dispensing kit
US4909243A (en) * 1988-07-20 1990-03-20 E. R. Squibb & Sons, Inc. Wound dressing system
US4948540A (en) * 1988-08-01 1990-08-14 Semex Medical, Inc. Method of preparing collagen dressing sheet material
US5002551A (en) * 1985-08-22 1991-03-26 Johnson & Johnson Medical, Inc. Method and material for prevention of surgical adhesions
US5007916A (en) * 1985-08-22 1991-04-16 Johnson & Johnson Medical, Inc. Method and material for prevention of surgical adhesions
US5055316A (en) * 1988-04-20 1991-10-08 Washington Research Foundation Tight binding of proteins to surfaces
US5059189A (en) * 1987-09-08 1991-10-22 E. R. Squibb & Sons, Inc. Method of preparing adhesive dressings containing a pharmaceutically active ingredient
US5067964A (en) * 1989-12-13 1991-11-26 Stryker Corporation Articular surface repair
US5099003A (en) * 1987-10-15 1992-03-24 Biotest Pharma Gmbh Method of preparing a sterile plasma-protein solution containing fibrinogen and factor xiii
US5098417A (en) * 1990-04-12 1992-03-24 Ricoh Kyosan, Inc. Cellulosic wound dressing with an active agent ionically absorbed thereon
US5134229A (en) * 1990-01-12 1992-07-28 Johnson & Johnson Medical, Inc. Process for preparing a neutralized oxidized cellulose product and its method of use
US5141516A (en) * 1989-07-26 1992-08-25 Detweiler Mark B Dissolvable anastomosis stent and method for using the same
US5180398A (en) * 1990-12-20 1993-01-19 Johnson & Johnson Medical, Inc. Cellulose oxidation by a perfluorinated hydrocarbon solution of nitrogen dioxide
US5223420A (en) * 1985-03-01 1993-06-29 Institut National De La Sante Et De La Recherche Medicale Elastin-based product, a procedure for its preparation and its biological applications; in particular as biomaterials and artificial supports
US5238685A (en) * 1988-08-31 1993-08-24 Britcair Limited Wound dressing
US5330974A (en) * 1993-03-01 1994-07-19 Fibratek, Inc. Therapeutic fibrinogen compositions
US5393594A (en) * 1993-10-06 1995-02-28 United States Surgical Corporation Absorbable non-woven fabric
US5395923A (en) * 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
US5409703A (en) * 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
US5573757A (en) * 1993-10-04 1996-11-12 Alliance Pharmaceutical Corp. Viscoelastic compositions containing concentrated fluorinated compounds their method of preparation and their uses
US5643596A (en) * 1993-11-03 1997-07-01 Clarion Pharmaceuticals, Inc. Hemostatic patch
US5795584A (en) * 1993-01-27 1998-08-18 United States Surgical Corporation Post-surgical anti-adhesion device
US5821343A (en) * 1996-04-25 1998-10-13 Medtronic Inc Oxidative method for attachment of biomolecules to surfaces of medical devices
US5866165A (en) * 1997-01-15 1999-02-02 Orquest, Inc. Collagen-polysaccharide matrix for bone and cartilage repair
US5914118A (en) * 1995-12-26 1999-06-22 Sanwa Kagaku Kenkyusho Co., Ltd. Multi-layered drug containing film preparation having powder adhesive thereon
US5925552A (en) * 1996-04-25 1999-07-20 Medtronic, Inc. Method for attachment of biomolecules to medical devices surfaces
US5945319A (en) * 1996-04-25 1999-08-31 Medtronic, Inc. Periodate oxidative method for attachment of biomolecules to medical device surfaces
US5972366A (en) * 1994-11-28 1999-10-26 The Unites States Of America As Represented By The Secretary Of The Army Drug releasing surgical implant or dressing material
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6056970A (en) * 1998-05-07 2000-05-02 Genzyme Corporation Compositions comprising hemostatic compounds and bioabsorbable polymers
US6114495A (en) * 1998-04-01 2000-09-05 Cargill Incorporated Lactic acid residue containing polymer composition and product having improved stability, and method for preparation and use thereof
US6121232A (en) * 1997-01-31 2000-09-19 Omrix Biopharmaceuticals Sa Stabilized mixture comprising fibrinogen
US6214808B1 (en) * 1998-05-15 2001-04-10 Hogy Medical Co., Ltd. Hemostatic agent
US6261679B1 (en) * 1998-05-22 2001-07-17 Kimberly-Clark Worldwide, Inc. Fibrous absorbent material and methods of making the same
US20010025154A1 (en) * 1998-11-06 2001-09-27 Aventis Behring Gmbh Flexible wound covering based on fibrin and process for its production
US6306424B1 (en) * 1999-06-30 2001-10-23 Ethicon, Inc. Foam composite for the repair or regeneration of tissue
US20020012693A1 (en) * 2000-02-29 2002-01-31 Cohen Kelman I. Wound dressings with protease-lowering activity
US6365149B2 (en) * 1999-06-30 2002-04-02 Ethicon, Inc. Porous tissue scaffoldings for the repair or regeneration of tissue
US20020120348A1 (en) * 2000-12-21 2002-08-29 Melican Mora Carolynne Reinforced tissue implants and methods of manufacture and use
US20020173213A1 (en) * 2001-05-16 2002-11-21 Benjamin Chu Biodegradable and/or bioabsorbable fibrous articles and methods for using the articles for medical applications
US20030073663A1 (en) * 1997-06-25 2003-04-17 David M Wiseman Bioabsorbable medical devices from oxidized polysaccharides
US6585957B1 (en) * 2000-01-25 2003-07-01 Aeropharm Technology Incorporated Medicinal aerosol formulation
US6613324B1 (en) * 1991-02-28 2003-09-02 Bristol-Myers Squibb Company Adhesive for the gluing of biological tissues
US20030165482A1 (en) * 2000-09-01 2003-09-04 Eric Rolland Methods and compositions for tissue regeneration
US20030171052A1 (en) * 2001-09-28 2003-09-11 Vishal Bansal Stretchable nonwoven web and method therefor
US6632648B1 (en) * 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
US6649162B1 (en) * 1996-04-04 2003-11-18 Baxter Aktiengesellschaft Hemostatic sponge based on collagen
US20040001879A1 (en) * 2002-06-28 2004-01-01 Guo Jian Xin Hemostatic wound dressing and method of making same
US20040005350A1 (en) * 2002-06-28 2004-01-08 Looney Dwayne Lee Hemostatic wound dressings and methods of making same
US20040064878A1 (en) * 2002-07-16 2004-04-08 Walsh Patrick James Drain clearing apparatus and seals
US20040078077A1 (en) * 2002-10-18 2004-04-22 Francois Binette Biocompatible scaffold for ligament or tendon repair
US6733774B2 (en) * 2001-01-25 2004-05-11 Nycomed Pharma As Carrier with solid fibrinogen and solid thrombin
US20040101548A1 (en) * 2002-11-26 2004-05-27 Pendharkar Sanyog Manohar Hemostatic wound dressing containing aldehyde-modified polysaccharide
US20040101546A1 (en) * 2002-11-26 2004-05-27 Gorman Anne Jessica Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents
US20040101547A1 (en) * 2002-11-26 2004-05-27 Pendharkar Sanyog Manohar Wound dressing containing aldehyde-modified regenerated polysaccharide
US20040106344A1 (en) * 2002-06-28 2004-06-03 Looney Dwayne Lee Hemostatic wound dressings containing proteinaceous polymers
US20040120993A1 (en) * 2002-12-20 2004-06-24 Guanghui Zhang Hemostatic wound dressing and fabric and methods of making and using same
US6762336B1 (en) * 1998-01-19 2004-07-13 The American National Red Cross Hemostatic sandwich bandage
US20040137033A1 (en) * 2000-03-10 2004-07-15 Calhoun Christopher J. Resorbable thin membranes
US20040193088A1 (en) * 2003-03-25 2004-09-30 Looney Dwayne Lee Hemostatic wound dressings and methods of making same
US20050008632A1 (en) * 2001-02-13 2005-01-13 Dagmar Stimmeder Carrier with solid fibrinogen and solid thrombin
US20060127460A1 (en) * 2002-11-14 2006-06-15 Juridical Foundation The Chemosero-Therapeutic Research Institute Trombin-carrying bioabsorbable synthetic nonwoven fabric
US7179833B2 (en) * 2003-06-30 2007-02-20 Les Laboratoires Servier Method of synthesising perindopril and the pharmaceutically acceptable salts thereof
US20080002398A1 (en) * 2005-01-13 2008-01-03 Arch Beacon, S.L. Port Marker
US20080003272A1 (en) * 1998-12-23 2008-01-03 Zlb Behring Gmbh Fibrin adhesive granulate and method for its preparation
US20080206298A1 (en) * 2004-07-16 2008-08-28 Burkinshaw Brian D Enhanced biological autologous tissue adhesive composition and methods of preparation and use
US7666803B2 (en) * 2004-10-20 2010-02-23 Ethicon, Inc. Reinforced absorbable multilayered fabric for use in medical devices

Family Cites Families (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL262878A (fr) 1960-03-28
GB1183951A (en) 1967-05-01 1970-03-11 Parachem Corp Dressing for Wound
US3937223A (en) * 1974-04-19 1976-02-10 American Cyanamid Company Compacted surgical hemostatic felt
US4214582A (en) 1979-02-07 1980-07-29 The Kendall Company Surgical dressing
DE3012783C2 (de) * 1980-04-02 1982-03-18 Jean Walterscheid Gmbh, 5204 Lohmar Ausrückkupplung
CS235108B1 (cs) 1981-06-24 1985-05-15 Ivan Blazicek Hemostatická hmota
CS217243B1 (cs) 1981-06-24 1982-12-31 Ivan Blazicek Hemostatický plošný materiál
DE3212412C2 (de) 1982-04-02 1986-01-02 Dr. Ruhland Nachf. GmbH, 8425 Neustadt Gewebeverklebbare kollagene Wundauflage
NZ203706A (en) 1982-04-22 1986-03-14 Squibb & Sons Inc Occlusive multi-layer wound dressing and hydrocolloidal granules for wound treatment
CS238016B1 (cs) 1982-05-21 1985-11-13 Maxmilian Mozisek Hemostatické vstřebatelně zubní čípky
NZ205863A (en) 1982-10-18 1985-09-13 Johnson & Johnson Prod Inc Absorbable haemostatic material containing lactide and glycolide homopolymers and copolymers
IN159332B (fr) 1983-01-28 1987-05-02 Jai Mangal Sinha Thunuguntla
US4534349A (en) 1983-02-02 1985-08-13 Minnesota Mining And Manufacturing Company Absorbable sutureless nerve repair device
JPS6087225U (ja) 1983-11-21 1985-06-15 株式会社栗本製鉄所 回動スクリ−ン付浮動式除塵機
US4626253A (en) 1984-10-05 1986-12-02 Johnson & Johnson Products, Inc. Surgical hemostat comprising oxidized cellulose
JPS61200837U (fr) 1985-06-05 1986-12-16
JPS6247364U (fr) 1985-09-09 1987-03-24
CS253042B1 (en) 1985-09-25 1987-10-15 Maxmilian Mozisek Haemostatical material
JPH0431071Y2 (fr) 1986-12-26 1992-07-27
CA1322262C (fr) 1987-06-26 1993-09-21 Yoshito Ikada Peau artificielle
JP2585707B2 (ja) 1988-04-21 1997-02-26 三井石油化学工業株式会社 積層不織布
JPH02127033A (ja) 1988-09-26 1990-05-15 Arco Chem Technol Inc 多層吸収材粒子及びその製法
CA2004740A1 (fr) 1988-12-07 1990-06-07 Cary Linsky Heparine, heparinoide et hexuronyl hexosaminoglucan sulfate a faible poids muleculaire contenant une barriere pour prevenir l'adhesion et procede de preparation
FR2650508A1 (fr) 1989-08-01 1991-02-08 Fondation Nale Transfusion San Colle pasteurisee pour reunir des tissus humain ou animal
JPH0731672Y2 (ja) 1989-10-16 1995-07-19 株式会社エーユーイー研究所 カートリッジの取付構造
JPH03176064A (ja) 1989-12-05 1991-07-31 Hoechst Japan Ltd 創面被覆材
AU658359B2 (en) 1989-12-19 1995-04-13 Procter & Gamble Company, The Disposable sanitary garments
US5026589A (en) 1989-12-28 1991-06-25 The Procter & Gamble Company Disposable sanitary articles
JPH0741731Y2 (ja) 1990-01-08 1995-09-27 株式会社小森コーポレーション 印刷機排紙部の紙流れ防止装置
WO1991016063A1 (fr) 1990-04-26 1991-10-31 Uab Research Foundation Systeme de cryoprecipitation de fibrinogene
WO1991018571A1 (fr) 1990-06-01 1991-12-12 Richard Crangle Systeme de bandage jetable sous pression a usages multiples
FR2663229B1 (fr) 1990-06-14 1995-06-23 Brothier Laboratoires Compresse composite pour le pansement de plaies et procede de sa fabrication.
FR2663841A1 (fr) 1990-06-27 1992-01-03 Lhd Lab Hygiene Dietetique Pansement hemostatique compressif.
CN1035803C (zh) 1990-07-24 1997-09-10 中国化工进出口总公司 可溶性止血织物
WO1992013495A1 (fr) 1991-02-07 1992-08-20 Fibratek, Inc. Adhesif a base de fibrinogene
CH681693A5 (fr) 1991-02-28 1993-05-14 Pentapharm Ag
JP2988641B2 (ja) 1991-04-09 1999-12-13 宇部日東化成株式会社 不織布用ポリオレフィン系複合繊維及び不織布
US5270300A (en) 1991-09-06 1993-12-14 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
WO1993010731A1 (fr) 1991-12-06 1993-06-10 Kensey Nash Corporation Tampons, leurs procedes de fabrication et d'utilisation comme pansements de plaies, renforcements chirurgicaux et promoteurs de l'hemostase
DE69328691T2 (de) 1992-02-26 2000-08-31 Univ Tennessee Res Corp Neue verbundbahn
WO1993017635A1 (fr) 1992-03-04 1993-09-16 C.R. Bard, Inc. Prothese composite et procede de limitation de la frequence d'adhesions post-operatoires
US5272074A (en) 1992-04-23 1993-12-21 Mcmaster University Fibrin coated polymer surfaces
US5263629A (en) * 1992-06-29 1993-11-23 Ethicon, Inc. Method and apparatus for achieving hemostasis along a staple line
DE69326349T2 (de) 1992-11-12 2000-03-02 Zymogenetics Inc Verwendung von lokal appliziertem faktor xiii zur verhinderung von blutungen
CA2114282A1 (fr) 1993-01-28 1994-07-29 Lothar Schilder Implant multi-couches
GB2280850B (en) 1993-07-28 1997-07-30 Johnson & Johnson Medical Absorbable composite materials for use in the treatment of periodontal disease
GB2280372B (en) 1993-07-28 1997-12-03 Johnson & Johnson Medical Composite surgical material
JPH07207560A (ja) 1994-01-12 1995-08-08 Honshu Paper Co Ltd 乾式不織布製造用パルプの製造方法
WO1996017633A1 (fr) * 1994-12-07 1996-06-13 The American National Red Cross Colles tissulaires adjuventees et non adjuventees, procedes de production et d'utilisation
JPH08302553A (ja) 1995-05-10 1996-11-19 Daiwabo Co Ltd 嵩高性不織布及びその製造方法
US6500777B1 (en) 1996-06-28 2002-12-31 Ethicon, Inc. Bioresorbable oxidized cellulose composite material for prevention of postsurgical adhesions
GB2314842B (en) 1996-06-28 2001-01-17 Johnson & Johnson Medical Collagen-oxidized regenerated cellulose complexes
IN192791B (fr) 1996-06-28 2004-05-22 Johnson & Johnson Medical
GB2314840B (en) 1996-06-28 2000-09-06 Johnson & Johnson Medical Oxidized oligosaccharides and pharmaceutical compositions
US5843057A (en) * 1996-07-15 1998-12-01 Kimberly-Clark Worldwide, Inc. Film-nonwoven laminate containing an adhesively-reinforced stretch-thinned film
DE69812759D1 (de) 1997-05-16 2003-05-08 Ethicon Inc Mehrschichtige Kompressionsbandage
US6565878B2 (en) 1997-07-02 2003-05-20 Coloplast A/S Method for preparing a non-fibrous porous material
US6165217A (en) 1997-10-02 2000-12-26 Gore Enterprise Holdings, Inc. Self-cohering, continuous filament non-woven webs
JPH11170413A (ja) 1997-12-11 1999-06-29 Asahi Chem Ind Co Ltd 不織布複合低密度織物
US6115476A (en) 1998-06-30 2000-09-05 Intel Corporation Active digital audio/video signal modification to correct for playback system deficiencies
RU2146264C1 (ru) 1998-08-10 2000-03-10 Институт эколого-технологических проблем Способ получения высокоокисленной целлюлозы и высокоокисленная целлюлоза "биоакцеллин"
US20020197302A1 (en) * 1998-11-12 2002-12-26 Cochrum Kent C. Hemostatic polymer useful for rapid blood coagulation and hemostasis
GB2344519B (en) 1998-12-07 2004-05-19 Johnson & Johnson Medical Ltd Sterile therapeutic compositions
ES2183606T5 (es) * 1998-12-23 2008-05-16 Csl Behring Gmbh Granulado de adhesivo de fibrina y procedimiento para su preparacion.
KR20010008911A (ko) 1999-07-06 2001-02-05 박평렬 폴리올레핀 섬유, 부직포 및 그 제조방법
AU7432700A (en) 1999-09-18 2001-04-24 Path Tech Limited Separation method
US6653520B1 (en) 1999-09-23 2003-11-25 Innovative Global Inc. Wound dressing
WO2001023653A1 (fr) 1999-09-27 2001-04-05 Bhk Holding Ltd. Tissu absorbant
JP3576063B2 (ja) 2000-02-22 2004-10-13 株式会社ホギメディカル 凝固蛋白質を含む可溶性創傷治癒止血セルロース繊維とその製造方法
JP4314421B2 (ja) 2000-02-28 2009-08-19 グンゼ株式会社 心臓弁基材およびその製造方法、並びに心臓弁の再生方法
AU2000258249A1 (en) 2000-07-04 2002-01-14 C.T.P. Cable Technology Procurement Ag Wound dressing comprising a therapeutically active agent
JP2002017764A (ja) 2000-07-07 2002-01-22 Unitika Ltd 排泄物パウチ用脱臭材
CN1455659A (zh) 2000-09-12 2003-11-12 弗吉尼亚州立大学 高压出血的治疗
US6500464B2 (en) 2000-12-28 2002-12-31 Ortec International, Inc. Bilayered collagen construct
AR032800A1 (es) * 2001-01-25 2003-11-26 Nycomed Pharma As Una suspension que comprende fibrinogeno, trombina y alcohol, un metodo para preparar dicha suspension, un metodo para recubrir un agente con dicha suspension, y un metodo para secar un recubrimiento de un agente, y una esponja de colageno recubierta
CZ20033097A3 (cs) 2001-05-21 2004-06-16 Omrix Biopharmaceuticals S.A. Způsob odstranění plasmin(ogenu) z proteinových roztoků
US7371403B2 (en) 2002-06-14 2008-05-13 Providence Health System-Oregon Wound dressing and method for controlling severe, life-threatening bleeding
US6800753B2 (en) 2001-09-04 2004-10-05 University Of Iowa Research Foundation Regenerated cellulose and oxidized cellulose membranes as potential biodegradable platforms for drug delivery and tissue engineering
US20030118651A1 (en) 2001-12-21 2003-06-26 Jampani Hanuman B. Bio-compatible means for controlled drug delivery to tissue and method of use
US20040040096A1 (en) 2002-09-03 2004-03-04 Lowell Saferstein Concomitant scouring and oxidation process for making oxidized regenerated cellulose
CA2509622C (fr) 2002-12-16 2012-02-21 Gunze Limited Film a usage medical comprenant de la gelatine et une matiere de renfort
EP1588722A4 (fr) 2003-01-20 2011-03-02 Chemo Sero Therapeut Res Inst Materiaux hemostatiques
JP2004232160A (ja) 2003-02-03 2004-08-19 Solotex Corp 不織布
RU2235539C1 (ru) 2003-04-25 2004-09-10 Филатов Владимир Николаевич Способ получения порошкообразного материала для остановки кровотечений
US20040241212A1 (en) * 2003-05-30 2004-12-02 Pendharkar Sanyog Manohar Biodegradable hemostatic wound dressings
GB0312426D0 (en) 2003-05-30 2003-07-09 Albachem Ltd Purification means
CA2530032C (fr) 2003-06-16 2015-11-24 Loma Linda University Medical Center Agent hemostatique multifonctionnel deployable
US20040265371A1 (en) * 2003-06-25 2004-12-30 Looney Dwayne Lee Hemostatic devices and methods of making same
DK1809342T3 (en) 2004-10-20 2015-08-17 Ethicon Inc absorbable hemostat
CN101084022A (zh) 2004-10-20 2007-12-05 伊西康公司 可吸收的止血物
US20060258995A1 (en) 2004-10-20 2006-11-16 Pendharkar Sanyog M Method for making a reinforced absorbable multilayered fabric for use in medical devices
JP4749187B2 (ja) 2006-03-24 2011-08-17 三洋電機株式会社 冷却貯蔵庫
CA2649081A1 (fr) 2006-04-10 2007-10-18 Ethicon, Inc. Pansement hemostatique multicouche absorbable, renforce et procede de production

Patent Citations (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2517772A (en) * 1945-05-11 1950-08-08 Parke Davis & Co Neutralized oxidized cellulose products
US2914444A (en) * 1950-12-12 1959-11-24 David F Smith Cellulosic hemostatic composition
US2772999A (en) * 1952-06-06 1956-12-04 Johnson & Johnson Hemostatic surgical compositions and dressings
US2773000A (en) * 1952-06-06 1956-12-04 Johnson & Johnson Hemostatic surgical dressings
US3122479A (en) * 1957-11-14 1964-02-25 David F Smith Hemostatic surgical dressings
US3364200A (en) * 1960-03-28 1968-01-16 Johnson & Johnson Oxidized cellulose product and method for preparing the same
US3113568A (en) * 1961-12-26 1963-12-10 Eric K Erskine Styptic bandage
US3875937A (en) * 1963-10-31 1975-04-08 American Cyanamid Co Surgical dressings of absorbable polymers
US3328529A (en) * 1964-08-31 1967-06-27 Heath Co Phase shifting circuit for fm stereo receiver
US3868955A (en) * 1973-10-05 1975-03-04 Personal Products Co Aldehyde polysaccharide dressings
US4289824A (en) * 1977-04-22 1981-09-15 Avtex Fibers Inc. High fluid-holding alloy rayon fiber mass
US4176664A (en) * 1978-03-13 1979-12-04 Stanley Kalish Impregnated bandage
US4265233A (en) * 1978-04-12 1981-05-05 Unitika Ltd. Material for wound healing
US4366169A (en) * 1979-06-25 1982-12-28 Sun Tech, Inc. Use of perfluorocarbons as wound treatment
US4334530A (en) * 1980-09-12 1982-06-15 Hassell Donald S Indicia-bearing adhesive bandages
US4407787A (en) * 1980-10-03 1983-10-04 Dr. Ruhland Nachf. Gmbh Collagenous dressing
US4453939A (en) * 1981-02-16 1984-06-12 Hormon-Chemie Munchen Gmbh Composition for sealing and healing wounds
US4347841A (en) * 1981-03-11 1982-09-07 Human Oltoanyagtermelo Es Kutato Intezet Biological wound covering and method for producing same
US4427651A (en) * 1981-06-25 1984-01-24 Serapharm Michael Stroetmann Enriched plasma derivative for enhancement of wound closure and coverage
US4442655A (en) * 1981-06-25 1984-04-17 Serapharm Michael Stroetmann Fibrinogen-containing dry preparation, manufacture and use thereof
US4427650A (en) * 1981-06-25 1984-01-24 Serapharm Michael Stroetmann Enriched plasma derivative for advancement of wound closure and healing
US4858604A (en) * 1981-12-09 1989-08-22 Nippon Zoki Pharmaceutical Co., Ltd. Adhesive bandage
US4543410A (en) * 1982-06-21 1985-09-24 Morca, Inc. Absorbent cellulosic base structures
US4769028A (en) * 1983-04-27 1988-09-06 Lohmann Gmbh & Co. Kg Pharmaceutical product, in medical bandage form
US4704113A (en) * 1983-05-03 1987-11-03 The Kendall Company Dressing
US4600574A (en) * 1984-03-21 1986-07-15 Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte Method of producing a tissue adhesive
US4655211A (en) * 1984-08-09 1987-04-07 Unitika Ltd. Hemostatic agent
US5223420A (en) * 1985-03-01 1993-06-29 Institut National De La Sante Et De La Recherche Medicale Elastin-based product, a procedure for its preparation and its biological applications; in particular as biomaterials and artificial supports
US4616644A (en) * 1985-06-14 1986-10-14 Johnson & Johnson Products, Inc. Hemostatic adhesive bandage
US5002551A (en) * 1985-08-22 1991-03-26 Johnson & Johnson Medical, Inc. Method and material for prevention of surgical adhesions
US5007916A (en) * 1985-08-22 1991-04-16 Johnson & Johnson Medical, Inc. Method and material for prevention of surgical adhesions
US4840626A (en) * 1986-09-29 1989-06-20 Johnson & Johnson Patient Care, Inc. Heparin-containing adhesion prevention barrier and process
US4752466A (en) * 1987-08-31 1988-06-21 Johnson & Johnson Products, Inc. Thrombin aerosol
US5059189A (en) * 1987-09-08 1991-10-22 E. R. Squibb & Sons, Inc. Method of preparing adhesive dressings containing a pharmaceutically active ingredient
US5099003A (en) * 1987-10-15 1992-03-24 Biotest Pharma Gmbh Method of preparing a sterile plasma-protein solution containing fibrinogen and factor xiii
US5055316A (en) * 1988-04-20 1991-10-08 Washington Research Foundation Tight binding of proteins to surfaces
US4909243A (en) * 1988-07-20 1990-03-20 E. R. Squibb & Sons, Inc. Wound dressing system
US4948540A (en) * 1988-08-01 1990-08-14 Semex Medical, Inc. Method of preparing collagen dressing sheet material
US4902281A (en) * 1988-08-16 1990-02-20 Corus Medical Corporation Fibrinogen dispensing kit
US5238685A (en) * 1988-08-31 1993-08-24 Britcair Limited Wound dressing
US5141516A (en) * 1989-07-26 1992-08-25 Detweiler Mark B Dissolvable anastomosis stent and method for using the same
US5067964A (en) * 1989-12-13 1991-11-26 Stryker Corporation Articular surface repair
US5134229A (en) * 1990-01-12 1992-07-28 Johnson & Johnson Medical, Inc. Process for preparing a neutralized oxidized cellulose product and its method of use
US5098417A (en) * 1990-04-12 1992-03-24 Ricoh Kyosan, Inc. Cellulosic wound dressing with an active agent ionically absorbed thereon
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US5180398A (en) * 1990-12-20 1993-01-19 Johnson & Johnson Medical, Inc. Cellulose oxidation by a perfluorinated hydrocarbon solution of nitrogen dioxide
US6613324B1 (en) * 1991-02-28 2003-09-02 Bristol-Myers Squibb Company Adhesive for the gluing of biological tissues
US5795584A (en) * 1993-01-27 1998-08-18 United States Surgical Corporation Post-surgical anti-adhesion device
US5395923A (en) * 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
US5330974A (en) * 1993-03-01 1994-07-19 Fibratek, Inc. Therapeutic fibrinogen compositions
US5409703A (en) * 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
US5573757A (en) * 1993-10-04 1996-11-12 Alliance Pharmaceutical Corp. Viscoelastic compositions containing concentrated fluorinated compounds their method of preparation and their uses
US5393594A (en) * 1993-10-06 1995-02-28 United States Surgical Corporation Absorbable non-woven fabric
US5643596A (en) * 1993-11-03 1997-07-01 Clarion Pharmaceuticals, Inc. Hemostatic patch
US5645849A (en) * 1993-11-03 1997-07-08 Clarion Pharmaceuticals, Inc. Hemostatic patch
US5972366A (en) * 1994-11-28 1999-10-26 The Unites States Of America As Represented By The Secretary Of The Army Drug releasing surgical implant or dressing material
US5914118A (en) * 1995-12-26 1999-06-22 Sanwa Kagaku Kenkyusho Co., Ltd. Multi-layered drug containing film preparation having powder adhesive thereon
US6649162B1 (en) * 1996-04-04 2003-11-18 Baxter Aktiengesellschaft Hemostatic sponge based on collagen
US5821343A (en) * 1996-04-25 1998-10-13 Medtronic Inc Oxidative method for attachment of biomolecules to surfaces of medical devices
US5945319A (en) * 1996-04-25 1999-08-31 Medtronic, Inc. Periodate oxidative method for attachment of biomolecules to medical device surfaces
US5925552A (en) * 1996-04-25 1999-07-20 Medtronic, Inc. Method for attachment of biomolecules to medical devices surfaces
US6632648B1 (en) * 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
US5866165A (en) * 1997-01-15 1999-02-02 Orquest, Inc. Collagen-polysaccharide matrix for bone and cartilage repair
US6121232A (en) * 1997-01-31 2000-09-19 Omrix Biopharmaceuticals Sa Stabilized mixture comprising fibrinogen
US20030073663A1 (en) * 1997-06-25 2003-04-17 David M Wiseman Bioabsorbable medical devices from oxidized polysaccharides
US6017741A (en) * 1997-12-31 2000-01-25 Medtronic, Inc. Periodate oxidative method for attachment and crosslinking of biomolecules to medical device surfaces
US6762336B1 (en) * 1998-01-19 2004-07-13 The American National Red Cross Hemostatic sandwich bandage
US6114495A (en) * 1998-04-01 2000-09-05 Cargill Incorporated Lactic acid residue containing polymer composition and product having improved stability, and method for preparation and use thereof
US6056970A (en) * 1998-05-07 2000-05-02 Genzyme Corporation Compositions comprising hemostatic compounds and bioabsorbable polymers
US6214808B1 (en) * 1998-05-15 2001-04-10 Hogy Medical Co., Ltd. Hemostatic agent
US6261679B1 (en) * 1998-05-22 2001-07-17 Kimberly-Clark Worldwide, Inc. Fibrous absorbent material and methods of making the same
US20010025154A1 (en) * 1998-11-06 2001-09-27 Aventis Behring Gmbh Flexible wound covering based on fibrin and process for its production
US20080003272A1 (en) * 1998-12-23 2008-01-03 Zlb Behring Gmbh Fibrin adhesive granulate and method for its preparation
US7572769B2 (en) * 1998-12-23 2009-08-11 Csl Behring Gmbh Fibrin adhesive granulate and method for its preparation
US6365149B2 (en) * 1999-06-30 2002-04-02 Ethicon, Inc. Porous tissue scaffoldings for the repair or regeneration of tissue
US6306424B1 (en) * 1999-06-30 2001-10-23 Ethicon, Inc. Foam composite for the repair or regeneration of tissue
US6585957B1 (en) * 2000-01-25 2003-07-01 Aeropharm Technology Incorporated Medicinal aerosol formulation
US20020012693A1 (en) * 2000-02-29 2002-01-31 Cohen Kelman I. Wound dressings with protease-lowering activity
US20040137033A1 (en) * 2000-03-10 2004-07-15 Calhoun Christopher J. Resorbable thin membranes
US20030165482A1 (en) * 2000-09-01 2003-09-04 Eric Rolland Methods and compositions for tissue regeneration
US20020120348A1 (en) * 2000-12-21 2002-08-29 Melican Mora Carolynne Reinforced tissue implants and methods of manufacture and use
US6733774B2 (en) * 2001-01-25 2004-05-11 Nycomed Pharma As Carrier with solid fibrinogen and solid thrombin
US20050008632A1 (en) * 2001-02-13 2005-01-13 Dagmar Stimmeder Carrier with solid fibrinogen and solid thrombin
US20020173213A1 (en) * 2001-05-16 2002-11-21 Benjamin Chu Biodegradable and/or bioabsorbable fibrous articles and methods for using the articles for medical applications
US20030171052A1 (en) * 2001-09-28 2003-09-11 Vishal Bansal Stretchable nonwoven web and method therefor
US20040001879A1 (en) * 2002-06-28 2004-01-01 Guo Jian Xin Hemostatic wound dressing and method of making same
US20040106344A1 (en) * 2002-06-28 2004-06-03 Looney Dwayne Lee Hemostatic wound dressings containing proteinaceous polymers
US20040005350A1 (en) * 2002-06-28 2004-01-08 Looney Dwayne Lee Hemostatic wound dressings and methods of making same
US20040064878A1 (en) * 2002-07-16 2004-04-08 Walsh Patrick James Drain clearing apparatus and seals
US20040078077A1 (en) * 2002-10-18 2004-04-22 Francois Binette Biocompatible scaffold for ligament or tendon repair
US20060127460A1 (en) * 2002-11-14 2006-06-15 Juridical Foundation The Chemosero-Therapeutic Research Institute Trombin-carrying bioabsorbable synthetic nonwoven fabric
US20040101548A1 (en) * 2002-11-26 2004-05-27 Pendharkar Sanyog Manohar Hemostatic wound dressing containing aldehyde-modified polysaccharide
US20040101546A1 (en) * 2002-11-26 2004-05-27 Gorman Anne Jessica Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents
US20040101547A1 (en) * 2002-11-26 2004-05-27 Pendharkar Sanyog Manohar Wound dressing containing aldehyde-modified regenerated polysaccharide
US20040120993A1 (en) * 2002-12-20 2004-06-24 Guanghui Zhang Hemostatic wound dressing and fabric and methods of making and using same
US20040193088A1 (en) * 2003-03-25 2004-09-30 Looney Dwayne Lee Hemostatic wound dressings and methods of making same
US7179833B2 (en) * 2003-06-30 2007-02-20 Les Laboratoires Servier Method of synthesising perindopril and the pharmaceutically acceptable salts thereof
US20080206298A1 (en) * 2004-07-16 2008-08-28 Burkinshaw Brian D Enhanced biological autologous tissue adhesive composition and methods of preparation and use
US7666803B2 (en) * 2004-10-20 2010-02-23 Ethicon, Inc. Reinforced absorbable multilayered fabric for use in medical devices
US7749204B2 (en) * 2004-10-20 2010-07-06 Ethicon, Inc. Reinforced absorbable multilayered fabric for use in tissue repair and regeneration
US20080002398A1 (en) * 2005-01-13 2008-01-03 Arch Beacon, S.L. Port Marker

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110237994A1 (en) * 2010-03-25 2011-09-29 Combat Medical Systems, Llc Void-filling wound dressing
WO2015079433A1 (fr) 2013-11-26 2015-06-04 Omrix Biopharmaceuticals Ltd. Tampon sec comprenant de la thrombine et de la pectine
US11484623B2 (en) 2013-11-26 2022-11-01 Omrix Biopharmaceuticals Ltd. Dry pad comprising thrombin and pectin

Also Published As

Publication number Publication date
CA2584679C (fr) 2015-01-27
CN102091347A (zh) 2011-06-15
WO2006044882A2 (fr) 2006-04-27
JP5133061B2 (ja) 2013-01-30
ES2552233T3 (es) 2015-11-26
JP2008516736A (ja) 2008-05-22
BRPI0516764B1 (pt) 2020-01-21
EP1809343A2 (fr) 2007-07-25
ES2391641T3 (es) 2012-11-28
US20060093655A1 (en) 2006-05-04
EP2052746A3 (fr) 2012-10-10
CA2584698A1 (fr) 2006-04-27
TWI365078B (en) 2012-06-01
IL182564A0 (en) 2007-07-24
BRPI0516761A (pt) 2008-09-16
KR101342872B1 (ko) 2013-12-19
TWI401097B (zh) 2013-07-11
WO2006044879A2 (fr) 2006-04-27
CA2584698C (fr) 2014-02-25
WO2006044882A3 (fr) 2006-09-08
EP2052746B1 (fr) 2014-11-26
AU2005295365A1 (en) 2006-04-27
TW200630126A (en) 2006-09-01
IL182564A (en) 2015-05-31
CA2584679A1 (fr) 2006-04-27
EP2837393A1 (fr) 2015-02-18
US20060257458A1 (en) 2006-11-16
AU2005295365B2 (en) 2010-08-05
BRPI0516764A (pt) 2008-09-16
US20060088589A1 (en) 2006-04-27
HK1130704A1 (en) 2010-01-08
JP5191736B2 (ja) 2013-05-08
TW200630125A (en) 2006-09-01
KR20070095870A (ko) 2007-10-01
IL182565A (en) 2011-01-31
HK1207009A1 (en) 2016-01-22
EP1809342A2 (fr) 2007-07-25
ES2530989T3 (es) 2015-03-09
BRPI0516761B8 (pt) 2021-05-25
EP1809343B1 (fr) 2012-08-15
IL182565A0 (en) 2007-07-24
DK1809342T3 (en) 2015-08-17
WO2006044879A3 (fr) 2006-08-17
EP2052746A2 (fr) 2009-04-29
BRPI0516764B8 (pt) 2021-05-25
EP1809342B1 (fr) 2015-08-05
BRPI0516761B1 (pt) 2020-01-21
KR20070092701A (ko) 2007-09-13
AU2005295368A1 (en) 2006-04-27
DK1809343T3 (da) 2012-11-26
DK2052746T3 (en) 2014-12-08
JP2008516735A (ja) 2008-05-22
PL1809342T3 (pl) 2015-12-31
FR14C0026I1 (fr) 2014-05-02
US9439997B2 (en) 2016-09-13
AU2005295368B2 (en) 2011-06-09

Similar Documents

Publication Publication Date Title
CA2584679C (fr) Hemostatique
US20040101546A1 (en) Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents
CN101084022A (zh) 可吸收的止血物
US6056970A (en) Compositions comprising hemostatic compounds and bioabsorbable polymers
RU2627426C2 (ru) Гемостатическое биологически абсорбируемое устройство с полиэтиленгликолем в качестве связующего вещества
CN102939113B (zh) 止血海绵
Peng et al. Novel wound sealants: Biomaterials and applications
KR101213460B1 (ko) 지혈용 재료
US8299316B2 (en) Hemostatic device
US20040106344A1 (en) Hemostatic wound dressings containing proteinaceous polymers
CN107754005B (zh) 止血组合物及其制造方法
JP2004202202A (ja) 止血用の傷用包帯および布地およびこれらの作成および使用の方法
Peng Biomaterials for hemorrhage control
US11484623B2 (en) Dry pad comprising thrombin and pectin
KR20130090882A (ko) 조직 접착용 시트 제제

Legal Events

Date Code Title Description
AS Assignment

Owner name: ETHICON, INC., NEW JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ZHANG, GUANGHUI;MARTINS, SONIA;BARONE, ROBIN;REEL/FRAME:020193/0924

Effective date: 20071203

Owner name: OMRIX BIOPHARMACEUTICALS, INC., NEW YORK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ZHANG, GUANGHUI;MARTINS, SONIA;BARONE, ROBIN;REEL/FRAME:020193/0924

Effective date: 20071203

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION